Biomarin Pharmaceutical (BMRN) Technical (Analysis) Reports Biomarin Pharmaceutical ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Biomarin Pharmaceutical (BMRN)
Technical Analysis Report for USA stock BMRN Biomarin Pharmaceutical. Dated: 30 Jan 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock BMRN Biomarin Pharmaceutical then click here. or read Experts views on Biomarin Pharmaceutical or Forecast & share price targets of Biomarin Pharmaceutical
Biomarin Pharmaceutical Opened at 63.77 and Closed at: 63.88, which is 0.66% of previous session's close. It moved within a range of 63.43 and 64.23
The session was a Bullish session with an average volume of 1096300, which is 14.44% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 63.66 and resistance for tomorrow is 64.46
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 63.46, 63.05 resistance for tomorrow's hourly charts is 64.26, 64.65
10 Day SMA for Biomarin Pharmaceutical (BMRN) is 62.39 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Biomarin Pharmaceutical (BMRN) is 64.18 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Biomarin Pharmaceutical (BMRN) is 64.91 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 68.49 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Biomarin Pharmaceutical is 76.42 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Biomarin Pharmaceutical is at 64.18 and 200 DMA is at 76.42, while 50 DMA and 100 DMA are at 64.91 and 68.49 respectively
Biomarin Pharmaceutical (BMRN) moving average of 20 SMA is at 64.18 and 20 EMA is at 63.69
Date | Closing Price | 20 SMA | 20 EMA |
30 Thu Jan | 63.88 | 64.18 | 63.69 |
29 Wed Jan | 63.46 | 64.33 | 63.67 |
28 Tue Jan | 63.25 | 64.48 | 63.69 |
27 Mon Jan | 61.80 | 64.61 | 63.74 |
24 Fri Jan | 61.73 | 64.79 | 63.94 |
23 Thu Jan | 62.19 | 65.05 | 64.17 |
Biomarin Pharmaceutical (BMRN) moving average of 50 SMA is at 64.91 and 50 EMA is at 65.47
Date | Closing Price | 50 SMA | 50 EMA |
30 Thu Jan | 63.88 | 64.91 | 65.47 |
29 Wed Jan | 63.46 | 64.96 | 65.54 |
28 Tue Jan | 63.25 | 65.03 | 65.63 |
27 Mon Jan | 61.80 | 65.1 | 65.73 |
24 Fri Jan | 61.73 | 65.19 | 65.89 |
23 Thu Jan | 62.19 | 65.28 | 66.06 |
Biomarin Pharmaceutical (BMRN) moving average of 100 SMA is at 68.49 and 100 EMA is at 69.06
Date | Closing Price | 100 SMA | 100 EMA |
30 Thu Jan | 63.88 | 68.49 | 69.06 |
29 Wed Jan | 63.46 | 68.76 | 69.16 |
28 Tue Jan | 63.25 | 69.04 | 69.28 |
27 Mon Jan | 61.80 | 69.32 | 69.4 |
24 Fri Jan | 61.73 | 69.62 | 69.55 |
23 Thu Jan | 62.19 | 69.9 | 69.71 |
Biomarin Pharmaceutical (BMRN) moving average of 200 SMA is at 76.42 and 200 EMA is at 74.33
Date | Closing Price | 200 SMA | 200 EMA |
30 Thu Jan | 63.88 | 76.42 | 74.33 |
29 Wed Jan | 63.46 | 76.56 | 74.44 |
28 Tue Jan | 63.25 | 76.7 | 74.55 |
27 Mon Jan | 61.80 | 76.83 | 74.66 |
24 Fri Jan | 61.73 | 76.97 | 74.79 |
23 Thu Jan | 62.19 | 77.1 | 74.92 |
Biomarin Pharmaceutical has performed better than Xtl Biopharmaceuticals in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Walgreens Boots has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Walgreens Boots, about 25.77% more returns!
Urogen Pharma has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Urogen Pharma, about 7.85% more returns!
Tandem Diabetes has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Tandem Diabetes, about 3.82% more returns!
Biomarin Pharmaceutical has performed better than Syros Pharmaceuticals in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Sutro Biopharma has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Sutro Biopharma, about 0.35% more returns!
Biomarin Pharmaceutical has performed better than Sarepta Therapeutics in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Insulet Corporation has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Insulet Corporation, about 9.09% more returns!
Phio Pharmaceuticals has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Phio Pharmaceuticals, about 25.41% more returns!
Pavmed Inc has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Pavmed Inc, about 9.45% more returns!
Krystal Biotech has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Krystal Biotech, about 4.93% more returns!
Kamada has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Kamada, about 5.81% more returns!
Biomarin Pharmaceutical has performed better than Harrow Health in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Galapagos Nv in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Fonar Corporation has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Fonar Corporation, about 7.95% more returns!
Biomarin Pharmaceutical has performed better than Corvus Pharmaceuticals in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Biomarin Pharmaceutical has performed better than Atara Biotherapeutics in short term. Holding Biomarin Pharmaceutical could be a better choice for now!
Amgen Inc has performed better than Biomarin Pharmaceutical in short term. You could have earned much better returns by investing in Amgen Inc, about 14.59% more returns!
Biomarin Pharmaceutical Technical analysis of indicators
Price action analysis of Biomarin Pharmaceutical (BMRN) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Biomarin Pharmaceutical stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Biomarin Pharmaceutical in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Biomarin Pharmaceutical Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Biomarin Pharmaceutical in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Biomarin Pharmaceutical is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 62.17 and Biomarin Pharmaceutical BMRN stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Biomarin Pharmaceutical BMRN stock. Volume based technical analysis of Biomarin Pharmaceutical BMRN stock is negative.
Biomarin Pharmaceutical Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock BMRN Biomarin Pharmaceutical These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And BMRN Experts View which covers a lot of information including buying and selling signals
BMRN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Biomarin Pharmaceutical or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Biomarin Pharmaceutical (BMRN) Technical (Analysis) Reports Biomarin Pharmaceutical ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance